Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR).

Full DD Report for ARWR

You must become a subscriber to view this report.


Recent News from (NASDAQ: ARWR)

Arrowhead Pharmaceuticals Could Become The Next Gilead
Arrowhead Pharmaceuticals ( ARWR ) announced clinical data on Thursday, September 6, 2018. The data was with regard to their Hepatitis B Virus (HBV) infection treatment known as ABO-HBV, a potential cure for a currently incurable treatment. The data showed promising results from the viewpoin...
Source: SeekingAlpha
Date: September, 07 2018 13:14
Arrowhead Pharmaceuticals (ARWR) Presents At 18th World Gastroenterologists Summit - Slideshow
The following slide deck was published by Arrowhead Pharmaceuticals in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 07 2018 12:36
Arrowhead's Data Proves That It Can Be A Big Contender In The Hepatitis B Space
Recently, Arrowhead Pharmaceuticals ( ARWR ) announced initial results for its Hepatitis B clinical candidate ARO-HBV. These results were highly positive, and the reason why the stock closed the day higher on Thursday by 37.52% to $19.39 per share. These initial positive results for its ARO-...
Source: SeekingAlpha
Date: September, 07 2018 10:06
Today's Research Reports on Stocks to Watch: Arrowhead Pharmaceuticals and Iovance Biotherapeutics
NEW YORK, NY / ACCESSWIRE / September 7, 2018 / Arrowhead Pharmaceuticals exploded on positive data results on Thursday while shares of Iovance Biotherapeutics were deep in the red on its own concerning clinical update. RDI Initiates Coverage on: Arrowhead Pharmaceuticals, Inc. htt...
Source: ACCESSWIRE IA
Date: September, 07 2018 08:00
Midday Gainers / Losers (09/06/2018)
Gainers: ARWR +45% . WSCI +34% . CVM +28% . ABAC +24% . CLDR +23% . SDPI +22% . NBEV +17% . SUPV +17% . AVAV +17% . IMMP +15% . More news on: Arrowhead Pharmaceuticals, WSI Industries Inc., Cel-Sci Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 06 2018 13:03
Healthcare Stocks Take Center Stage In September
CORAL GABLES, FL / ACCESSWIRE / September 6, 2018 / The healthcare industry has become one of the fastest growing industries in the world. The growing advancements in the industry are steadily contributing towards its market growth. According to the findings of the latest study, expansion i...
Source: ACCESSWIRE IA
Date: September, 06 2018 10:45
Premarket Gainers as of 9:05 am (09/06/2018)
ARWR +31%  on positive analyst action . More news on: Arrowhead Pharmaceuticals, New Age Beverages Corporation, Naked Brand Group Limited, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 06 2018 09:26
Arrowhead's HBV candidate shows positive action in early-stage study; shares up 16% premarket
Arrowhead Pharmaceuticals (NASDAQ: ARWR ) is up  16%  premarket on light volume in response to its announcement of encouraging data from a Phase 1/2 clinical trial evaluating the safety, tolerability and pharmacokinetics of single ascending doses of RNAi therapeutic ARO-HBV i...
Source: SeekingAlpha
Date: September, 06 2018 08:17
Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
Data presented from the lowest two dose cohorts (100mg and 200mg ARO-HBV) Up to 4.0 log10 reduction in HBsAg observed following three doses of ARO-HBV ARO-HBV was generally well-tolerated in HBV patients Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) will present initial clin...
Source: Business Wire
Date: September, 06 2018 07:30
Small Caps Are Rising, Biotechs Can't Be Far Behind
Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...
Source: SeekingAlpha
Date: September, 05 2018 13:31

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0819.4119.7420.5018.9014,744,664
2018-05-179.499.539.829.44971,514
2017-06-201.651.631.681.60522,169
2017-06-191.591.651.671.55550,962
2017-06-161.641.591.681.55654,013

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-11139,604277,61750.2865Short
2018-12-1069,212160,73543.0597Short
2018-12-07153,946279,67755.0442Short
2018-12-06126,000357,97235.1983Short
2018-12-04209,121365,80257.1678Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ARWR.


About Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)

Logo for Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)

Not available

 

Contact Information

 

 

Current Management

  • Christopher Anzalone / CEO
  • Joseph T. Kingsley / CFO
  • Ken Myszkowski / CFO

Current Share Structure

  • Market Cap: $817,538,872 - 05/14/2018
  • Issue and Outstanding: 86,787,566 - 02/07/2018

 


Recent Filings from (NASDAQ: ARWR)

Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 09 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 06 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: January, 25 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: January, 25 2018

 

 


Daily Technical Chart for (NASDAQ: ARWR)

Daily Technical Chart for (NASDAQ: ARWR)


Stay tuned for daily updates and more on (NASDAQ: ARWR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ARWR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARWR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ARWR and does not buy, sell, or trade any shares of ARWR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/